Literature DB >> 3949149

Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex.

P M Beart, D McDonald, M Cincotta, D J de Vries, A L Gundlach.   

Abstract

The affinities of several ergot derivatives for 5-HT1 and 5-HT2 receptors were evaluated using [3H]5-HT and [3H]mianserin, and membranes prepared from rat frontal cortex. CQ 32-084, which had a Ki value against the 5-HT2 component of [3H]mianserin binding of 9 nM, had little effect on [3H]5-HT binding and was selective for the 5-HT2 receptor. Lisuride and LY-158A also displayed preferential affinity for the 5-HT2 receptor. Dihydroergocryptine, CM 29-712, lergotrile and LY-062 were more selective for the 5-HT1 receptor. Bromocriptine showed little selectivity for either subtype. Overall, the ergot derivatives displayed markedly different affinities and selectivities for central 5-HT receptors suggesting that their serotonergic actions should be considered when evaluating their pharmacological spectrum of activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3949149     DOI: 10.1016/0306-3623(86)90011-x

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

Review 1.  The motor effects of bromocriptine--a review.

Authors:  D M Jackson; O F Jenkins; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Striking differences of action of lisuride stereoisomers at histamine H1 receptors.

Authors:  Heinz H Pertz; Tilo Görnemann; Björn Schurad; Roland Seifert; Andrea Strasser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-08       Impact factor: 3.000

3.  Possible antidepressant dihydroergosine preferentially binds to 5-HT1B receptor sites in the rat hippocampus.

Authors:  D Muck-Seler; D Pericić
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies.

Authors:  D M Jackson; N Mohell; J Georgiev; A Bengtsson; L G Larsson; O Magnusson; S B Ross
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-02       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.